businesspress24.com - AMP German Cannabis Group plans name change to AMP Alternative Medical Products
 

AMP German Cannabis Group plans name change to AMP Alternative Medical Products

ID: 1563620

(firmenpresse) -
ERFURT/BERLIN, Germany, January 11th, 2021 - AMP German Cannabis Group Inc. (AMP and or the Company) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces its intention to change its corporate name to AMP Alternative Medical Products Inc. The new corporate name aligns with AMPs brand name and logo for medical and wellness cannabis products, which AMP will be launching for sale in Germany this quarter.

The Companys trading symbol on the Canadian Securities Exchange will not change. The Company will announce the new CUSIP and ISIN numbers and, if required, a new Frankfurt Stock Exchange trading symbol when the name change becomes effective.

About AMP German Cannabis Group

AMP German Cannabis Group is licensed to import European Union - Good Manufacturing Practice (EU-GMP) medical cannabis from Europe and elsewhere into Germany. AMP sources, stores, transports, delivers, and sells medical cannabis products to pharmaceutical distributors or pharmacists directly, the only point-of-sale for medical cannabis to German patients with a physicians prescription. AMP has entered into a non-exclusive distribution agreement for medical cannabis with a leading distributor of pharmaceuticals products to more than 13,000 pharmacies throughout Germany.

AMP has sponsored a six-episode roundtable discussion series about medical cannabis in Germany. The Roundtable Series is available by podcast or video. In Episode #2 titled, Politics and Medical Cannabis in Germany, Dr. Wieland Schinnenburg, MdB (FDP) provides an up-to-date overview of the political issues and challenges facing the medical cannabis industry in Germany. The panel also includes Dr. Stefan Feuerstein, President of AMP and Mr. Holger Scholze as moderator. AMP Roundtable Series: www.amp-eu.de/roundtable
For more information, please visit: www.amp-eu.com

Mr. Alex Blodgett, CEO and Director
Email: investor(at)amp-eu.com
AMP social media links:




- Twitter: https://twitter.com/AMP_Cannabis
- LinkedIn: www.linkedin.com/company/ampgermancannabisgroup
- Facebook: www.facebook.com/AMPGCG
- Instagram: www.instagram.com/ampgcg
- Podcast: http://ow.ly/EqBc50BJ4xw
Media Kit: https://www.amp-eu.com/media-kit

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking statements that are based on the Company''s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to its business plans and milestones and the timing thereof. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.

SOURCE AMP German Cannabis Group Inc.




Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:





PresseKontakt / Agentur:



Bereitgestellt von Benutzer: irw
Datum: 11.01.2021 - 03:21 Uhr
Sprache: Deutsch
News-ID 1563620
Anzahl Zeichen: 7384

contact information:
Contact person:
Town:

Wien


Phone:

Kategorie:

Business News


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 195 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"AMP German Cannabis Group plans name change to AMP Alternative Medical Products

"
steht unter der journalistisch-redaktionellen Verantwortung von

AMP German Cannabis Group Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von AMP German Cannabis Group Inc.



 

Who is online

All members: 10 568
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 70


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.